Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractional Shares

1,540.60
+0.19560.01%
Number of Gainers:318
Number of Losers:698
Number of Flat:19
PE:- -
High:1,544.54
Open:1,540.47
Low:1,537.31
Close:1,540.41
Loading ...

Shell ‘unlikely’ to buy all of BP, CNBC reports

TIPRANKS
·
10 hours ago

Exclusive-Ford Motor to Require Most Salaried Staff in Office 4 Days a Week Starting September 1

THOMSON REUTERS
·
10 hours ago

Phibro Animal Health Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
10 hours ago

Lloyds Banking Group Announces Share Buyback and Cancellation of Over 2 Million Shares

Reuters
·
10 hours ago

NXP Semiconductors (NXPI) Receives a Hold from Bernstein

TIPRANKS
·
10 hours ago

Bernstein Remains a Hold on Texas Instruments (TXN)

TIPRANKS
·
10 hours ago

“Many Pieces of the Puzzle” AeroVironment Stock (NASDAQ:AVAV) Soars Up Nearly 22%

TIPRANKS
·
10 hours ago

European Commission opens in-depth investigation into Kellanova buyout

TIPRANKS
·
10 hours ago

Cumberland's linked address has received 454 million USDT from Tether in the past 2 days and has subsequently dispersed it to multiple CEXs

Blockbeats
·
10 hours ago

Sparebanken Norge Renews Employee Equity Program

TIPRANKS
·
10 hours ago

Sage Group Executes Share Buyback as Part of Capital Optimization Strategy

TIPRANKS
·
10 hours ago

Hewlett Packard Enterprise Co - KDDI and Hpe to Launch AI Data Center by Early 2026

THOMSON REUTERS
·
10 hours ago

EU Sets Oct 31 2025 Deadline for Decision on Deal

THOMSON REUTERS
·
10 hours ago

EU Antitrust Regulators to Investigate Mars' $36 Bln Takeover of Kellanova

THOMSON REUTERS
·
10 hours ago

the Transaction Could Lead to Higher Prices for Consumers Due to Mars' Increasednegotiating Power Towards Retailers in the European Economic Area, EU Regulators Say

THOMSON REUTERS
·
10 hours ago

SBM Offshore NV Continues Share Buyback Program at Average Price of EUR 22.78

Reuters
·
10 hours ago

Novo Nordisk’s Semaglutide Study: A Potential Breakthrough for Alzheimer’s?

TIPRANKS
·
10 hours ago

Pfizer’s New Phase 1 Study: Exploring PF-07999415’s Potential

TIPRANKS
·
10 hours ago

Pfizer’s Inclacumab Study: A Long-term Safety Evaluation for Sickle Cell Disease

TIPRANKS
·
11 hours ago

EXCLUSIVE: Bitcoin Is HIVE's War Chest - Who Needs Bankers?

Benzinga
·
11 hours ago